TORL-3-600

· TORL Biotherapeutics, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TORL-3-600, covering 2025-10-10 to 2025-10-10. Get the full timeline:

Most recent: Clinical Trial Update: First in Human Study of TORL-3-600 in Participants With Advanced Cancer [Phase 1]